Status:
COMPLETED
A New Pharmacotherapy for Alcohol Dependence: Olanzapine
Lead Sponsor:
The Mind Research Network
Conditions:
Alcohol Dependence
Eligibility:
All Genders
21-55 years
Phase:
PHASE3
Brief Summary
Craving for alcohol has been related to loss of control drinking and is a major target of biological and behavioral interventions for alcohol dependence. Our previous research has demonstrated that ol...
Detailed Description
The first goal of the study is to determine whether olanzapine is effective at reducing cue-elicited craving (i.e., subjective craving as well as activation of the midbrain and prefrontal cortex after...
Eligibility Criteria
Inclusion
- 21-55 years of age with
- Alcohol Dependence
Exclusion
- Medical Contraindications
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT00746785
Start Date
September 1 2002
End Date
September 1 2011
Last Update
March 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Mind Research Network
Albuquerque, New Mexico, United States, 87131